Surrozen Publishes Study In 'ELife' Highlihgitng Potential To Enhance Wnt-Signal Activation In Targeted SWEETS Bispecific Antibodies
Surrozen Publishes Study In 'ELife' Highlihgitng Potential To Enhance Wnt-Signal Activation In Targeted SWEETS Bispecific Antibodies
Surrozen在《ELife》上發表研究，強調有可能通過定向的SWEETS雙特異性抗體來增強 Wnt信號激活。
Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment approaches
定向蛋白降解（TPD*技術已展示出生產新型治療方法的潛力
Surrozen's current SWEETS bispecific antibodies are unique TPD technologies
Surrozen目前的SWEETS雙特異性抗體是獨特的TPD技術
Results demonstrated that the two new ASGR-targeted SWEETS bispecific antibodies enhanced Wnt-signal activation through the unique TPD platform
結果表明，兩個新的ASGR靶向SWEETS雙特異性抗體通過獨特的TPD平台增強了Wnt信號激活
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。